Products

See leaflet

Inaro®
anagrelide

Indications

  • Reduces the elevated Platelet Count, the Risk of Thrombosis and improve the symptoms associated with them, such as Thromboembolic events in patients with Thrombocythemia Secondary to Myeloproliferative Disorders.

Presentations

  • 0,5 mg x 100 capsules
  • 1 mg x 100 capsules